Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori

References

• MA Arangoa, G Ponchel, AM Orecchioni, MJ Renedoi, D Duchene, and JM Irache. 2000. Bioadhesive potential of gliadin nanoparticles systems. Eur J Pharm Sci 11:333–341.
   PubMed Web of Science ®Google Scholar
• F Ascencio, JL Guruge, A Ljungh, F Megraud, S Wei, and T Wadstrm. 1990. Lectin typing of Helicobacter pylori. P Malfertheiner, and H Ditschuneit. Helicobacter pylori, gastritis and peptic ulcer. Berlin: Springer-Verlag. 105–109.
   Google Scholar
• KD Bardhan, C Dallaire, H Eisold, and AE Duggan. 1997. Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer. Gut 41:181–186.
   PubMed Web of Science ®Google Scholar
• M Benaissa, P Babin, N Quellard, L Pezennec, A Cenatiempo, and JL Fauchere. 1996. Changes in Helicobacter pylori ultrastructure and antigens during conversion from the bacillary to the coccoid from. Infect Immun 64:2331–2335.
   PubMed Web of Science ®Google Scholar
• N Chiba, BV Rao, JW Rademaker, and RH Hunt. 1992. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 87:1716–1727.
   PubMed Web of Science ®Google Scholar
• MJ Copland, MA Baird, T Rades, JL McKenzie, B Becker, F Reck, PC Tyler, and nM Davies. 2003. Liposomal delivery of antigen to human dendritic cells. Vaccine 21:883–890.
   PubMed Web of Science ®Google Scholar
• C Doglioni, AC Wotherspoon, A Moschini, M De Boni, and PG Isaacson. 1992. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 339:834–835.
   PubMed Web of Science ®Google Scholar
• BE Dunn. 1993. Pathogenic mechanisms of Helicobacter pylori. Gastroenterol Clin North Am 22:43–57.
   PubMed Web of Science ®Google Scholar
• C Durrer, JM Irache, F Puisieux, D Duchene, and G Ponchel. 1994. Mucoadhesion of latexes. II. Adsorption isotherms and desorption studies. Pharm Res 11:680–683.
   PubMed Web of Science ®Google Scholar
• D Forman, DG Newell, F Fullerton, JW Yarnell, AR Stacey, N Wald, and F Sitas. 1991. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 302:1302–1305.
   PubMed Web of Science ®Google Scholar
• CS Goodwin. 1994. Haemagglutinins of Helicobacter pylori and adherence to Hep-2 cells. G Gasbarrini, and S Pretolani. Basic and clinical aspects of Helicobacter pylori infection. Berlin, Heidelberg: Springer Verlag. 90–91.
   Google Scholar
• PK Gupta, SH Leung, and JR Robinson. 1990. Bioadhesive drug delivery systems, Boca Raton, FL: CRC Press. 6592.
   Google Scholar
• LE Gustavson, JF Kaiser, AL Edmond, CS Locke, MI DeBartolo, and DW Schneck. 1995. Effect of omeprazole on concentration of clarithromycin in plasma and gastric tissue at study state. Antimicrob Agents Chemother 39 (9):2078–2083.
   PubMed Web of Science ®Google Scholar
• JM Irache, C Durrer, D Duchene, and G Ponchel. 1994. Preparation and characterization of lectin–latex conjugates for specific bioadhession. Biomaterials 15:899–904.
   PubMed Web of Science ®Google Scholar
• RAH Ishak, GAS Awad, ND Mortada, and SAK Nour. 2007. Preparation, in vitro and in vivo evaluation of stomach specific metronidazole loaded alginate beads as local anti-Helicobacter pylori therapy. J Control Release 119:207–214.
   PubMed Web of Science ®Google Scholar
• V Kate, and N Ananthakrishnan. 2001. Treatment of Helicobacter pylori infection—A review. Indian J Pharmcol 33:410–416.
   Google Scholar
• Y Kawashima, H Yamamoto, H Takeuchi, and Y Kuno. 2000. Mucoadhesive d,l-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol 5:77–85.
   PubMed Web of Science ®Google Scholar
• SK Kulkarni, and M Gupta. 1999. Current concepts and drug therapy of Helicobacter pylori infection. Indian J Pharm Sci 61 (6):323–334.
   Google Scholar
• BJ Marshall. 1991. Virulence and pathogenicity of Helicobacter pylori. J Gastroenterol Hepatol 6:121–124.
   PubMed Web of Science ®Google Scholar
• BJ Marshall, and JR Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet I:1311–1315.
   Google Scholar
• S Moss, and J Calam. 1992. Helicobacter pylori and peptic ulcers: The present position. Gut 33:289–292.
   PubMed Web of Science ®Google Scholar
• N Nagagara, Y Akiyama, M Nakao, M Tada, M Kitano, and Y Ogawa. 1998. Mucoadhessive microspheres containing amoxicillin for clearance of Helicobacter pylori. Antimicrob Agents Chemother 42:2492–2494.
   PubMed Web of Science ®Google Scholar
• N O'Sullivan, J Benjamin, and MB Skirrow. 1990. Lectin typing of Campylobacter isolates. J Clin Pathol 43:957–960.
   PubMed Web of Science ®Google Scholar
• LH Olde Damink, PJ Dijkstra, MJ van Luyn, PB van Wachem, P Nieuwenhuis, and J Feijen. 1996. In vitro degradation of dermal sheep cpllegen cross-linked using a water soluble carbodiimide. Biomaterials 17:679–684.
   PubMed Web of Science ®Google Scholar
• U Peitz, M Sulliga, K Wolle, A Leodolter, U von Arnim, S Kahl, and et al 2002. High rate of post-therapeutic resistance after failure of macrolide nitromidazole triple therapy to cure Helicobacter pylori infection: Impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther 16:315–324.
   PubMed Web of Science ®Google Scholar
• NA Peppas, and Y Huang. 2004. Nanoscale technology of mucoadhessive interaction. Adv Drug Deliv Rev 56:1675–1687.
   PubMed Web of Science ®Google Scholar
• WL Peterson, DY Graham, B Marshall, MJ Blaser, RM Genta, PD Klein, and et al 1993. Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomized, double blind trial. Am J Gastroenterol 88:1860–1864.
   PubMed Web of Science ®Google Scholar
• MR Prausnitz, BS Lau, CD Milano, S Conner, R Langer, and JC Weaver. 1993. A quantitative study of electroporation showing a plateau in net molecular transport. Biophys J 65:414–422.
   PubMed Web of Science ®Google Scholar
• D Rajotte, W Arap, M Hagedorn, E Koivunen, R Pasqualini, and E Ruoslahti. 1998. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest 102:430–437.
   PubMed Web of Science ®Google Scholar
• S Ramteke, and NK Jain. 2008. Clarithromycin and omeprazole containing gliadin nanoparticles for the treatment of Helicobacter pylori. J Drug Target 16 (1):65–72.
   PubMed Web of Science ®Google Scholar
• S Ramteke, RB Umamaheshwari, and NK Jain. 2006. Clarithromycin based oral sustained release nanoparticulate drug delivery system. Indian J Pharm Sci 68 (4):479–484.
   Google Scholar
• N Sharon, and H Lis. 1972. Lectins. Cell agglutinating and sugar specific proteins. Science 177:949–959.
   PubMed Web of Science ®Google Scholar
• JE Sjostrom, J Fryklund, T Kuhler, and H Larsson. 1996. In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions. J Med Microbiol 44 I:425–433.
   Google Scholar
• DN Taylor, and MJ Blaser. 1991. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 13:42–59.
   PubMed Web of Science ®Google Scholar
• RB Umamaheshwari, and NK Jain. 2003. Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori. J Drug Target 11 (7):415–424.
   PubMed Web of Science ®Google Scholar
• RB Umamaheshwari, P Jain, and NK Jain. 2003a. Site-specific drug delivery of acetohydroxamic acid for the treatment of H. pylori. STP Pharm Sci 13 (1):41–48.
   Google Scholar
• RB Umamaheshwari, S Jain, D Bhadra, and NK Jain. 2003b. Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori. J Pharm Pharmacol 55:1607–1613.
   PubMed Web of Science ®Google Scholar
• RB Umamaheshwari, S Jain, and NK Jain. 2003c. A new approach in gastroretentive drug delivery system using Cholestyramine. Drug Deliv 10:151–160.
   PubMed Web of Science ®Google Scholar
• RB Umamaheshwari, S Ramteke, and NK Jain. 2004. Anti Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gabrils model. AAPS Pharm Sci Tech 5 (2):1–9.
   Google Scholar
• JK Vasir, MK Reddy, and VD Labhasetwar. 2005. Nanosystems in drug targeting: Opportunities and challenges. Curr Nanosci 1:47–64.
   Web of Science ®Google Scholar
• J Wang, Y Tabata, D Bi, and K Morimoto. 2001. Evaluation of gastric mucoadhessive properties of aminated gelatin microspheres. J Control Release 73:223–231.
   PubMed Web of Science ®Google Scholar
• KH Wong, SK Skelton, and JC Feeley. 1986. Strain characterization and grouping of Campylobacter jejuni and Campylobacter coli by interaction with lectins. J Clin Microbiol 23:407–410.
   PubMed Web of Science ®Google Scholar
• AC Wotherspoon, C Ortiz-Hidalgo, MR Falzon, and PG Isaacson. 1991. Helicobacter pylori associated gastritis and primary B-cell lymphoma. Lancet 338:1175–1176.
   PubMed Web of Science ®Google Scholar
• RA Yokel, KM Dickey, and AH Goldberg. 1995. Selective adherence of a sucralfate-tetracycline complex to gastric ulcers: Implications for the treatment of Helicobacter pylori. Biopharm Drug Dispos 16:475–479.
   PubMed Web of Science ®Google Scholar